To further validate the regulatory role of the TGF‐β signaling pathway on C1R expression and its function in the EMT process of GBM cells, we designed exogenous TGF‐β addition experiments, conducting both dose‐dependent and time‐dependent TGF‐β stimulation experiments on GBM cells. This evidence concerns the gene TGFB1 and glioblastoma.